Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation

Publication Date: February 1, 2019
Last Updated: March 14, 2022

Consensus Statements

Hodgkin Lymphoma

1. The panel recommends post–autologous HCT consolidation/maintenance with BV for 16 cycles in BV-naïve classic Hodgkin lymphoma (HL) with at least 1 or more high-risk features as defined by the AETHERA study.a ( A )
609

BV, brentuximab vedontin; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; HCT, hematopoietic cell transplantation; HL, Hodgkin lymphoma; MCL, mantle cell lymphoma; IPI, International Prognostic Index; PET/CT, positron emission tomography/computed tomography

Overview

Title

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation

Authoring Organization